- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Immune Response of Host in Canada
Total 554 results
-
AbbVie (prior sponsor, Abbott)CompletedMultiple SclerosisUnited States, Canada, Germany, Netherlands, United Kingdom
-
Brigham and Women's HospitalThe Thompson Family Foundation IncCompletedHeart Failure | Infections | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Asthma | Anticoagulation | Gout Flare | Hypertensive Urgency | Atrial Fibrillation Rapid | Diabetes and Its Complications | End of Life/Desires Only Medical ManagementUnited States, Canada
-
Grifols Therapeutics LLCCompletedMultiple Sclerosis, Relapsing-RemittingCanada, Israel, United States, Austria, Czech Republic, Germany, Greece, Hungary, Poland, Slovakia, Sweden, United Kingdom
-
SanofiCompletedMultiple SclerosisHungary, Belgium, Germany, Italy, Greece, France, Poland, Spain, Canada, Switzerland, Czech Republic, Tunisia, United Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisCroatia, Bulgaria, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Lithuania, Poland, Belgium, Hungary, Serbia, Finland, Ukraine, Switzerland, Canada, Turkey
-
University of California, Los AngelesJohns Hopkins University; University of Colorado, Denver; Mayo Clinic; University... and other collaboratorsCompletedRelapsing Remitting Multiple SclerosisUnited States, Canada
-
SanofiRecruitingMultiple SclerosisIsrael, United States, Canada, Puerto Rico, United Kingdom, Chile, Turkey
-
Merz Pharmaceuticals GmbHCompletedPost-stroke Spasticity of the Lower LimbGermany, Poland, Spain, United States, Czech Republic, Russian Federation, Canada, France, Italy
-
University of PennsylvaniaActive, not recruiting
-
Janssen Research & Development, LLCCompletedErythroblastosis, Fetal | Early Onset Severe Hemolytic Disease of the Fetus and Newborn (EOS-HDFN)United States, Canada, Netherlands, Belgium, Australia, Germany, Spain, Sweden, United Kingdom
-
Acorda TherapeuticsCompleted
-
AbbVieCompletedMultiple Sclerosis (MS)United States, Canada
-
NovartisCompletedMultiple SclerosisUnited States, Canada
-
Cidara Therapeutics Inc.RecruitingMycoses | Candidemia | Fungemia | Fungal Infection | Invasive Candidiasis | Invasive Fungal Disease | Pneumocystis | Mold Infection | Prophylaxis of Invasive Fungal Infections | AspergillusUnited States, Germany, France, Belgium, Canada, Italy, Spain, United Kingdom, Turkey, Switzerland
-
Genzyme, a Sanofi CompanyActive, not recruitingMultiple SclerosisBelgium, United States, Bulgaria, Canada, China, Estonia, France, Greece, Israel, Lebanon, Lithuania, Morocco, Netherlands, Portugal, Russian Federation, Serbia, Spain, Tunisia, Turkey, Ukraine, United Kingdom
-
Grifols Therapeutics LLCCompletedPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingUnited States, Israel, Germany, Czech Republic, Mexico, Argentina, Canada, Italy, Poland, Serbia
-
SanofiCompletedRelapsing Multiple SclerosisFrance, United States, Canada, Czechia, Estonia, Netherlands, Russian Federation, Slovakia, Spain, Ukraine
-
CelgeneActive, not recruitingMultiple SclerosisUnited States, Canada, Puerto Rico
-
University of PennsylvaniaNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedTemporal ArteritisUnited States, Canada
-
IMS HEALTH GmbH & Co. OHGEMD SeronoCompletedRelapsing-remitting Multiple SclerosisUnited States, Canada
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple SclerosisCroatia, Bulgaria, France, Italy, Russian Federation, Spain, Turkey, Estonia, Germany, Latvia, Poland, Romania, Argentina, Israel, Portugal, Greece, Czech Republic, Slovakia, Serbia, Austria, Finland, Saudi Arabia, Belgium, Canada, Lebanon and more
-
Novartis PharmaceuticalsCompletedMultiple SclerosisColombia, Panama, Peru, Brazil, Jordan, Malaysia, Mexico, Argentina
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple SclerosisUnited Kingdom, Germany, Israel, Finland, Canada, Australia, Czechia, Spain, France, Italy, Austria, Hungary, Poland, Sweden
-
BayerCompletedMultiple SclerosisSpain, Belgium, Czechia, Italy, United Kingdom, Hungary, Germany, Switzerland, Austria, France, Poland, Canada, Sweden, Finland, Israel, Denmark, Norway, Portugal
-
National Institute of Diabetes and Digestive and...CompletedType 1 Diabetes | Preservation of Insulin Secretion | Newly Diagnosed Type 1 Diabetes | Canakinumab in Type 1 DiabetesUnited States, Canada
-
AbbVieCompletedMultiple Sclerosis (MS)United States, Canada
-
NovartisCompletedRelapsing Multiple SclerosisBelgium, Poland, Spain, France, United Kingdom, Guatemala, Canada, Finland, Switzerland
-
BayerCompletedRelapsing Remitting Multiple Sclerosis (RRMS)China, Slovakia, France, Germany, Korea, Republic of, Saudi Arabia, Singapore, Sweden, Taiwan, Colombia, Czech Republic, Estonia, Italy, Jordan, Lebanon, Mexico, Slovenia, United Kingdom, Argentina, Bahrain, Egypt, United Arab Emirates and more
-
EMD SeronoMerck KGaA, Darmstadt, GermanyTerminatedRelapsing Multiple SclerosisSweden, United States, Czech Republic, Russian Federation, Spain, United Kingdom, Lithuania, Ukraine, Netherlands, Canada, Germany, France, Switzerland, Australia, Belgium, Lebanon, New Caledonia
-
UCB PharmaBiogenTerminatedMultiple SclerosisUnited States, France, Germany, Spain, Canada, Netherlands, Belgium, Hungary, Sweden, United Kingdom, Finland
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis | Clinically Isolated SyndromeCroatia, Bulgaria, France, Italy, Russian Federation, Spain, Estonia, Germany, Latvia, Poland, Romania, Argentina, Finland, Israel, Greece, Czech Republic, Slovakia, Austria, Belgium, Canada, Lebanon, Morocco, Portugal, Serbia
-
EMD SeronoTerminatedRelapsing Multiple SclerosisUnited States, Sweden, Australia, Czech Republic, Russian Federation, Spain, United Kingdom, Germany, Lithuania, Ukraine, Netherlands, Canada, France, Austria, Lebanon, Switzerland, Belgium
-
BayerCompletedMultiple SclerosisBelgium, Italy, Spain, France, Switzerland, Israel, Czech Republic, Canada, Austria, Poland, Germany, Netherlands, United Kingdom, Hungary, Portugal, Finland, Norway, Sweden, Slovenia, Denmark
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisSpain, Australia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Relatives to/Carers of Patients | Healthcare ProfessionalsSpain, Algeria, China, India, Mexico, Russian Federation, Turkey, Germany, Poland, Japan, Netherlands, Italy, Canada, United Kingdom, Denmark, France, United States
-
Novartis PharmaceuticalsRecruitingMultiple SclerosisDenmark, Spain, Switzerland, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Colombia, Cyprus, Czechia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Mexico, Netherlands, Norway, Poland, ... and more
-
BiogenElan PharmaceuticalsCompletedMultiple Sclerosis, Relapsing-RemittingUnited Kingdom, United States, Canada, Belgium, Czech Republic, France, Germany, Netherlands
-
Duke UniversityPatient-Centered Outcomes Research Institute; Beth Israel Deaconess Medical...CompletedAutoimmune Diseases | Neurological DisorderUnited States, Canada
-
BayerCompletedMultiple SclerosisBelgium, Italy, Spain, France, Germany, Canada, Switzerland, Austria, Denmark, Hungary, Netherlands, Poland, Israel, United Kingdom, Finland, Sweden, Norway, Czech Republic, Portugal, Slovenia
-
Novartis PharmaceuticalsCompletedMyasthenia Gravis, GeneralizedTaiwan, Germany, Russian Federation, Denmark, Canada
-
ActelionTerminatedMultiple SclerosisUnited States, Germany, Hungary, Poland, United Kingdom, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Denmark, France, Greece, Italy, Mexico, Portugal, Russian Federation, Spain, Switzerland
-
SanofiCompletedMultiple SclerosisUnited States, Austria, Canada, Chile, Czech Republic, Denmark, Estonia, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Sweden, Switzerland, Turkey, Ukraine, United Kingdom
-
Genzyme, a Sanofi CompanyTerminatedRelapsing-remitting Multiple SclerosisSweden, Poland, Russian Federation, United States, Canada
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Canada
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); Hamilton Health Sciences Corporation and other collaboratorsRecruitingSingle Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS) (SNACS)Premature Birth | Pregnancy Complications | Preterm Birth | Obstetric Labor, Premature | Complication of PrematurityCanada, Australia
-
BiogenCompletedMultiple SclerosisUnited States, Spain, Hungary, Serbia, Canada, France, Poland, Russian Federation, Netherlands, Czech Republic, Italy, United Kingdom
-
BiogenCompletedMultiple SclerosisFrance, Spain, Germany, Netherlands, Argentina, Czechia, Israel, Portugal, United Arab Emirates, Canada, Norway, Lebanon, Ireland
-
Genentech, Inc.CompletedMultiple Sclerosis, Primary Progressive | Relapsing Multiple SclerorsisUnited States, Germany, Canada, Sweden
-
SanofiCompletedMultiple SclerosisUnited States, Australia, Austria, Bulgaria, Canada, Chile, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Lithuania, Mexico, Poland, Romania, Russian Federation, Turkey, Ukraine, United Kingdom
-
Clene NanomedicineClene Australia Pty LtdTerminatedRelapsing Remitting Multiple Sclerosis | Optic Neuropathy | Optic; Neuritis, With DemyelinationUnited States, Canada, Australia